Trial Profile
A Multi-center, Randomized, Double-masked, Placebo-controlled, Dose-ranging, Study of the Safety and Efficacy of Subcutaneous Injections of LIPO-102 Compared With Placebo for the Reduction of Abdominal Subcutaneous Adiposity
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 31 Mar 2015
Price :
$35
*
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary)
- Indications Subcutaneous fat disorders
- Focus Adverse reactions; Therapeutic Use
- Sponsors Lithera
- 08 Aug 2014 New trial record